Sentence examples for differs from previous trials from inspiring English sources

The incidence of hypoglycemia was not different between the EQW and detemir groups, which differs from previous trials that compared insulin with GLP-1 receptor agonists (7, 28, 29).

The TTM-trial differs from previous trials in several aspects, the most important one being that all patients received controlled temperature management avoiding fever in both intervention arms (Fig. 6).

In this respect, the present study differs from previous trials comparing prolonged therapy to placebo [ 10, 17, 18, 29].

This trial differs from previous trials because it investigates the additional value of MT as an adjuvant therapy to the usual care.

The TTM-trial differs from previous trials in several aspects, the most important one being that all patients received controlled temperature management avoiding fever in both intervention arms (Fig.  6).

Our results differ from previous trials of online alcohol interventions and this may reflect differences in study populations, trial procedures and comparator interventions [11] [13].

Our study differed from previous trials because smokers could choose one of two NRT products, gum or inhaler, and were given the opportunity to quit or reduce.

The OVA-301 study differed from previous trials in the same setting (e.g. CALYPSO) as it included only patients who were not expected to benefit from or who were ineligible for or who were unwilling to receive re-treatment with platinum-based chemotherapy.

The OVA-301 study differed from previous trials in the same setting as it included only patients who were not expected to benefit from or who were ineligible for or who were unwilling to receive re-treatment with platinum-based chemotherapy, including those with PPS and PR disease.

In addition to a shorter intervention period, our study differs from these previous trials in several ways.

Our study differs from the previous trials in specifically testing a more homogenous population of basal insulin treated patients and including both a period of stable insulin dosing, permitting robust assessment of the efficacy and safety of add-on linagliptin, and an extension period, during which patients were allowed to adjust the insulin according to the investigator criteria.